Icon (ICLR) Stock Highlights

143.12 | +4.63%

2025-04-23 23:17:11

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Statistics

Range Today

138.02 147.79

Volume Today 2.03M

Range 1 Year

133.28 347.72

Volume 1 Year 230.29M

Range 3 Year

133.28 347.72

Volume 3 Year 512.54M

Range 10 Year

62.31 347.72

Volume 10 Year 1.21B

Highlights

Market Capitalization 11.26B (large)

Floating Shares 79.62M

Current Price 143.12

Price To Earnings 14.94

Price To Revenue 1.73

Price To Book 1.18

Earnings Per Share 9.53

Payout Ratio 0%

Performance

Latest +4.63%

1 Month -22.64%

3 Months -29.28%

6 Months -49.09%

1 Year -52.33%

3 Years -36.87%

5 Years -12.63%

10 Years +106.08%

Benchmarks

Market Capitalization

7 / 58

Gross Profits

9 / 52

Total Revenue

6 / 57

Total Rank

4 / 58

Free Cashflow

9 / 56

Performance 5 years

25 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.